Metraipolis › archive › dc_c82aa4af116f

Real-World Outcomes of Avelumab Maintenance Therapy in Patients With Curatively Unresectable Urothelial Carcinoma in Japan: Results From the Final Analysis of… — Europe PMC PMID:41164966

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41164966
DOI
10.1002/cam4.71264
License (as archived)
solo-consultazione
Archived
2026-11-08T21:17:11.119Z
SHA-256 of the archived text
5a506580b35d2436fdbd9604c5c7e00ed646865c7712f457293d9e6d1230ff4c
Stable URL of this page
https://metraipolis.com/documento/dc_c82aa4af116f

How to cite

Real-World Outcomes of Avelumab Maintenance Therapy in Patients With Curatively Unresectable Urothelial Carcinoma in Japan: Results From the Final Analysis of… — Europe PMC PMID:41164966 — Europe PMC (en), https://europepmc.org/article/MED/41164966 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c82aa4af116f (Metraipolis archive dc_c82aa4af116f, sha256 5a506580b35d2436fdbd9604c5c7e00ed646865c7712f457293d9e6d1230ff4c)
BibTeX
@misc{dcc82aa4af116f,
  title = {Real-World Outcomes of Avelumab Maintenance Therapy in Patients With Curatively Unresectable Urothelial Carcinoma in Japan: Results From the Final Analysis of… — Europe PMC PMID:41164966},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41164966},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c82aa4af116f; sha256 5a506580b35d2436fdbd9604c5c7e00ed646865c7712f457293d9e6d1230ff4c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41164966. Agents can read the archived copy with the MCP tool read_document.